Accelerating the Decline of Tuberculosis (TB) in High Burden Countries and Settings

Closed Posted

Opportunity number
CDC-RFA-GH18-1838
Agency
Applications due
Award size
Up to $350,000

Opportunity facts

Assistance listings
Funding instrument
Cooperative Agreement
Category
  • Health
Eligible applicants
  • Other
Full announcement

Opportunity details come from Grants.gov. Updated .

Synopsis

2 versions

Update #2 · Latest ·

This amendment is for informational purposes only. CDC is not accepting new applications for award. The purpose of this amendment is to include language regarding HIV epidemic control under d. Other National Public Health Priorities and Strategies. - Despite being preventable and curable, TB is the leading infectious disease killer worldwide. A fourth of the world's population (2 billion people) are infected with TB, while more than 10 million become ill with the disease each year. More than 4 million individuals who become ill with TB are never diagnosed or treated, allowing TB to continue to be transmitted. Many of the "missing 4 million" are among vulnerable or underserved populations that are hard to reach or have difficulty accessing public health services, such as children, people living with HIV (PLHIV), migrants, refugees, and miners. The goal of this NOFO is to work with the Stop TB Partnership towards ending the TB epidemic by driving down TB deaths, TB incidence, and quantifying and eliminating catastrophic costs, in line with the WHO's END TB Strategy adopted by the World Health Assembly in May 2014. Through this NOFO, the Stop TB Partnership will develop models to expand TB screening and diagnosis to find the "missing" TB cases, increase efforts to address the intersecting epidemics of TB and HIV in high burden countries and settings, develop a global strategic plan to guide global TB partners in the implementation of the WHO END TB Strategy, and bolster collaboration and coordination among TB partners in a multi sectorial manner.

Update #1 ·

Despite being preventable and curable, TB is the leading infectious disease killer worldwide. A fourth of the world's population (2 billion people) are infected with TB, while more than 10 million become ill with the disease each year. More than 4 million individuals who become ill with TB are never diagnosed or treated, allowing TB to continue to be transmitted. Many of the "missing 4 million" are among vulnerable or underserved populations that are hard to reach or have difficulty accessing public health services, such as children, people living with HIV (PLHIV), migrants, refugees, and miners. The goal of this NOFO is to work with the Stop TB Partnership towards ending the TB epidemic by driving down TB deaths, TB incidence, and quantifying and eliminating catastrophic costs, in line with the WHO's END TB Strategy adopted by the World Health Assembly in May 2014. Through this NOFO, the Stop TB Partnership will develop models to expand TB screening and diagnosis to find the "missing" TB cases, increase efforts to address the intersecting epidemics of TB and HIV in high burden countries and settings, develop a global strategic plan to guide global TB partners in the implementation of the WHO END TB Strategy, and bolster collaboration and coordination among TB partners in a multi sectorial manner.

Files

File Type Posted
GH18-1838.pdf PDF
CDC-RFA-GH18-1838 Rev.pdf PDF
GH18-1838.pdf PDF
CDC-RFA-GH18-1838 Rev.pdf PDF
CDC-RFA-GH18-1838 Rev.pdf PDF
oppCDC-RFA-GH18-1838-cfda93.947-cidCDC-RFA-GH18-1838-instructions.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity